Latest Ratings for REVG Date Firm Action From To Mar 2022 Credit Suisse Maintains Underperform Dec 2021 Credit Suisse Maintains Underperform Dec 2021 Goldman Sachs Maintains Sell View More Analyst Ratings for REVG View the Latest Analyst Ratings read more
Latest Ratings for DVN Date Firm Action From To Mar 2022 Benchmark Downgrades Buy Hold Feb 2022 Piper Sandler Maintains Overweight Feb 2022 Raymond James Maintains Strong Buy View More Analyst Ratings for DVN View the Latest Analyst Ratings read more
Latest Ratings for OSK Date Firm Action From To Mar 2022 Wells Fargo Initiates Coverage On Equal-Weight Mar 2022 Raymond James Initiates Coverage On Outperform Feb 2022 Evercore ISI Group Downgrades Outperform In-Line View More Analyst Ratings for OSK View the Latest Analyst Ratings read more
Latest Ratings for WM Date Firm Action From To Mar 2022 JP Morgan Reinstates Neutral Oct 2021 Raymond James Maintains Outperform Jul 2021 Raymond James Maintains Outperform View More Analyst Ratings for WM View the Latest Analyst Ratings read more
Latest Ratings for TKR Date Firm Action From To Feb 2022 Evercore ISI Group Upgrades In-Line Outperform Jan 2022 B of A Securities Downgrades Buy Neutral Dec 2021 Goldman Sachs Downgrades Buy Neutral View More Analyst Ratings for TKR View the Latest Analyst Ratings read more
AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and metabolic drugs. read more
Sanofi acquires Vicebio for $1.15 billion, adding a next-gen RSV-hMPV vaccine and ‘Molecular Clamp’ tech to strengthen its respiratory vaccine pipeline. read more
PNC Bank will integrate Coinbase’s Crypto‑as‑a‑Service platform to expand secure digital asset offerings and tailored banking services for retail and institutional clients. read more
Danaher beat Q2 estimates and raised its 2025 earnings guidance as bioprocessing strength and cost control boosted profit margins and revenue. Latest Ratings for DHR Date Firm Action From To Jan 2022 Wells Fargo Maintains Overweight Jan 2022 Barclays Maintains Overweight Jan 2022 Bernstein Initiates Coverage On Outperform View More Analyst Ratings for DHR View…